Aclaris Therapeutics Inc Stock Price (ACRS)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by O Shaughnessy Asset Management LLCSat, 26 Nov 2022 06:40:42 UTC via ETF Daily News
Sigma Planning Corp Buys New Shares in CRISPR Therapeutics AG (NASDAQ:CRSP)Sat, 26 Nov 2022 05:46:43 UTC via ETF Daily News
Medicenna Therapeutics Corp. (NASDAQ:MDNA) Shares Bought by Sigma Planning CorpSat, 26 Nov 2022 05:46:42 UTC via ETF Daily News
Swiss National Bank Has $3.67 Million Stock Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Sat, 26 Nov 2022 05:24:47 UTC via ETF Daily News
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Acquired by Lazard Asset Management LLCSat, 26 Nov 2022 05:24:45 UTC via ETF Daily News
Insider Buying: Rain Therapeutics Inc. (NASDAQ:RAIN) Director Buys $351,000.00 in StockSat, 26 Nov 2022 05:22:47 UTC via ETF Daily News
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Given Average Rating of “Moderate Buy” by AnalystsSat, 26 Nov 2022 03:50:42 UTC via ETF Daily News
Head-To-Head Analysis: Better Therapeutics (BTTX) vs. The CompetitionSat, 26 Nov 2022 03:26:48 UTC via ETF Daily News
ProQR Therapeutics (NASDAQ:PRQR) Share Price Crosses Above 50 Day Moving Average of $0.93Sat, 26 Nov 2022 03:22:49 UTC via ETF Daily News
Onconova Therapeutics (NASDAQ:ONTX) Share Price Passes Below 200 Day Moving Average of $1.09Sat, 26 Nov 2022 03:00:48 UTC via ETF Daily News

Aclaris Therapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACRS

You don't have any alerts set for IEX:ACRS.

About Aclaris Therapeutics Inc

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

CEONeal S. Walker IndustryPharmaceuticals: Other SectorHealth Technology Websitehttp://www.aclaristx.com Issue ExchangeNASDAQ Issue TypeUnknown

Real-time ACRS to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.